Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine vs Sublingual Misoprostol for PPH Prevention in C-Section
NCT06364098Phase 1Completed
- Sponsor
- Cairo University
- Start
- Jan 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Cairo University. Primary endpoint: Amount of Blood Loss at 6 hours. Started Jan 2022; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT06364098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06364098.